![Thomas Folinsbee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Folinsbee
Direktor/Vorstandsmitglied bei
CASI PHARMACEUTICALS, INC.
Vermögen: - $ am 31.03.2026
Profil
Thomas Folinsbee currently works at Shanghai Alebund Pharmaceuticals Ltd., as Director-Business Development from 2019 and CASI Pharmaceuticals, Inc., as Independent Director from 2023.
Mr. Folinsbee also formerly worked at 3SBio, Inc., as Director-Corporate Development from 2009 to 2019, Hisanaga Seisakusho Co. Ltd., as Director from 2011 to 2016, Bison Capital Acquisition Corp., as Independent Director from 2017 to 2019, Xynomic Pharmaceuticals Holdings, Inc., as Independent Director, and Summit Healthcare Acquisition Corp., as Independent Director.
Mr. Folinsbee received his undergraduate degree in 1990 from McGill University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.04.2026 | 0 ( -.--% ) | - $ | 31.03.2026 |
Aktive Positionen von Thomas Folinsbee
| Unternehmen | Position | Beginn |
|---|---|---|
| CASI PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 21.03.2023 |
Shanghai Alebund Pharmaceuticals Ltd. | Corporate Officer/Principal | 01.01.2019 |
Ehemalige bekannte Positionen von Thomas Folinsbee
| Unternehmen | Position | Ende |
|---|---|---|
Bison Capital Acquisition Corp.
 Bison Capital Acquisition Corp. Financial ConglomeratesFinance Operates as blank check company | Direktor/Vorstandsmitglied | 01.01.2019 |
| 3SBIO INC. | Corporate Officer/Principal | 01.01.2019 |
Hisanaga Seisakusho Co. Ltd. | Direktor/Vorstandsmitglied | 01.01.2016 |
| SUMT HEAL | Direktor/Vorstandsmitglied | - |
| XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Thomas Folinsbee
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
88
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
3SBio, Inc.
 3SBio, Inc. BiotechnologyHealth Technology Engages in research, development, manufacturing and marketing of biopharmaceutical products | Health Technology |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hisanaga Seisakusho Co. Ltd. | |
Bison Capital Acquisition Corp.
Bison Capital Acquisition Corp. Financial ConglomeratesFinance Operates as blank check company | Finance |
Xynomic Pharmaceuticals Holdings, Inc.
 Xynomic Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and supplies oncology drugs | Health Technology |
Summit Healthcare Acquisition Corp.
 Summit Healthcare Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Shanghai Alebund Pharmaceuticals Ltd. | |
CASI Pharmaceuticals, Inc.
 CASI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics and pharmaceutical products | Health Technology |
